News and insights
Articles from the BioPhotonix team on the science, the regulation and the business of treating dry AMD in the community, and a weekly insight: one piece of new research or news in eye care, from anywhere in the world, read for what it means in practice.
Weekly insight · 9 November 2026 · 4 min read
Car drivers must report retinopathy lasered in both eyes. In a re-analysis, untreated eyes with severe retinopathy lost about as much field by year 3.
Read the articleWeekly insight · 9 November 2026 · 4 min read
Diabetic eye screening every 2 years rests on a 354,549-person study. In a North East London replay, 39% of sight-threatening diagnoses slipped a screen.
Read the articleWeekly insight · 2 November 2026 · 4 min read
Only 6 of 47 cosmetic lens websites met UK law in 2023. In Japan, buying lenses outside eye clinics went with more self-reported eye problems.
Read the articleWeekly insight · 2 November 2026 · 3 min read
A firework eye injury is four times more likely in October and November. The Diwali data adds the number the UK never had: six hours to presentation.
Read the articleWeekly insight · 26 October 2026 · 4 min read
The US approved pegcetacoplan for geographic atrophy on scans. Europe refused it: acuity, reading and microperimetry showed no benefit in two years.
Read the articleWeekly insight · 26 October 2026 · 4 min read
Two UK trials started patients on something other than glaucoma eye drops. Both found less field loss, and patients who could not feel the difference.
Read the articleWeekly insight · 19 October 2026 · 4 min read
Scotland pays approved prescribing optometrists to treat ten eye conditions. Under 1% of Greater Manchester's urgent cases in 2024 were prescribing cases.
Read the articleWeekly insight · 19 October 2026 · 4 min read
In young volunteers in glasses that cut acuity and contrast, a 6/12 cut-off caught 61% of plate failures near the cut-off, against 97% for blur alone.
Read the articleWeekly insight · 12 October 2026 · 4 min read
Glaucoma was 12.2% of 104,190 optometrist e-referrals in Greater Manchester, the top reason, and 10.2% were sent to hospital with no subspecialty named.
Read the articleWeekly insight · 12 October 2026 · 4 min read
In a review of AI in eye care, 27 of 29 results in its table top 90%. It does not say who carries the risk when one is wrong.
Read the articleWeekly insight · 5 October 2026 · 4 min read
Glaucoma sight loss certificates in England rose from 1,648 to 2,645 a year between 2009/10 and 2024/25, while diabetic eye disease fell.
Read the articleWeekly insight · 5 October 2026 · 4 min read
A global model forecasts 21.34 million with sight loss from AMD by 2050. What the stage split underneath it means for macular degeneration in the UK.
Read the articleWeekly insight · 28 September 2026 · 4 min read
In eight Scottish health boards, squint found at screening in children aged 3.5 to 5.5 rose from 1.42% to 2.19%. Who should see it, and how fast.
Read the articleWeekly insight · 28 September 2026 · 4 min read
A 95-trial analysis of atropine for myopia control ranks 0.01% 16th of 24 on refraction, and finds no rebound above its threshold once the drop stops.
Read the articleWeekly insight · 24 September 2026 · 4 min read
Patient satisfaction with opticians rose to 89% in 2026. Value for money scored lowest, and younger and ethnic minority patients were less satisfied.
Read the articleWeekly insight · 21 September 2026 · 4 min read
1.2 million people examined, before and after OCT. Referrals to public eye care rose from 0.55% to 1.74%, the extra subacute and routine, not acute.
Read the article6 February 2026 · 3 min read
As an optometrist and orthoptist, the hardest part of a dry AMD diagnosis was never the diagnosis. It was the conversation that followed.
Read the article6 February 2026 · 3 min read
There is a clear line between consumer wellness gadgets and regulated medical devices. We have chosen our side of it with absolute clarity.
Read the article6 February 2026 · 3 min read
Around 200 million people live with AMD today, and 85 to 90% of them have the dry form. For decades the innovation has gone to the other 10%.
Read the article31 December 2025 · 3 min read
We have moved beyond proof of concept and into advanced prototype development. Here is how we are turning our vision into a medical reality.
Read the article